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Objectives: The endotoxemia associated with cardiac surgery is thought to be
dominantly influenced by the use of cardiopulmonary bypass. The objectives of this
study were to assess the relative contribution of cardiopulmonary bypass on endo-
toxemia apart from cardiac surgical access and to improve our understanding of the
potential benefits of off-pump procedures.
Methods: Thirty patients undergoing coronary artery bypass grafting were followed
up prospectively. The patients were divided into 2 equal groups: those who under-
went bypass grafting through a sternotomy incision without cardiopulmonary by-
pass (off-pump group) and those who underwent bypass grafting through a sternot-
omy incision with cardiopulmonary bypass (CPB group). Blood sampling for
endotoxin, lactate, and cardiac index measurements were performed during the
following time points: (1) after sternotomy; (2) during the coronary occlusion period
in the off-pump group and during aortic clamping in the CPB group; (3) after
removal of the coronary occlusion sutures in the off-pump group and after removal
of the aortic clamp in the CPB group; (4) 30 minutes after the completion of all
distal anastomoses in the off-pump group and immediately after weaning from
cardiopulmonary bypass in the CPB group; (5) 1 hour postoperatively; and (6) 12
hours postoperatively.
Results: Endotoxin and lactate levels were significantly (P  .05) lower in the
off-pump group at all sampling time points, except after sternotomy.
Conclusions: In conclusion, this study has shown that endotoxemia during coronary
artery bypass surgery seems mainly to be associated with cardiopulmonary bypass
procedure. The relatively lower endotoxin levels observed in off-pump surgery
might contribute to improved postoperative recovery.
Endotoxin is a lipopolysaccharide from the cell wall of gram-negativebacteria and is recognized to be a major stimulus for the develop-ment of the systemic inflammatory response syndrome.1Transient endotoxemia in patients undergoing surgery involvingcardiopulmonary bypass (CPB) has been widely recognized.2-11 Theendotoxemia associated with cardiac surgery is thought to be dom-
inantly influenced by the use of CPB. Gut translocation has traditionally been
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perceived as the primary source of endotoxemia. However,
the pathogenesis involved in this phenomenon is not en-
tirely clear.
In an attempt to avoid the deleterious effects of CPB,
off-pump coronary artery bypass grafting (CABG) has re-
cently been rediscovered. Because the data for the clinical
benefits of beating-heart surgery are being substantiated at
midterm and now at longer-term follow-up, the basic sci-
ence behind these differences is still lacking. Many studies
have been conducted to compare different inflammatory
responses after CABG with or without CPB.12-17 To our
knowledge, there is no literature available about the com-
parison of blood endotoxin levels between off-pump and
conventional coronary artery bypass surgery with CPB.
The objectives of this study were to assess the relative
contribution of CPB on endotoxemia apart from cardiac
surgical access and to improve our understanding of the
potential benefits of off-pump procedures.
Patients and Methods
Patients
Thirty patients undergoing CABG were followed prospectively
from September through November 2001. The study was approved
by the Institutional Committee on Human Research, and all pa-
tients provided informed consent. The patients were divided into 2
groups: those who underwent bypass grafting through a sternot-
omy incision without CPB (the off-pump group) and those who
underwent bypass grafting through a sternotomy incision with
CPB (CPB group). Exclusion criteria were as follows: redo or
emergency operations, active or prior history of autoimmune dis-
orders, medication with immunomodulating agents (eg, steroids),
increased white blood cell counts, increased C-reactive protein
levels, high sedimentation rates, any history or signs of infectious
disease before surgical intervention, previous major abdominal
operations, disorders involving the intestines, connective tissue
disorders, and abdominal aorta and mesenteric artery diseases. All
patients had multivessel coronary artery disease on the basis of
preoperative cardiac catheterization and ejection fractions of
greater than 35%. The decision regarding which procedure was to
be performed on an individual basis was made by the attending
surgeon in consultation with the patient. Patients with diseases
involving the posterior descending or circumflex coronary arteries
were considered candidates for either procedure.
Preoperative urine and blood cultures were obtained from each
patient. Patients with positive blood or urine culture results were
also excluded from the study.
Anesthesia
Before the operation, the radial artery was cannulated, and a
flow-directed thermodilution catheter (Abbott Critical Care Sys-
tems) was inserted into the pulmonary artery percutaneously
through the internal jugular vein. All patients received a similar
balanced anesthetic regimen, including fentanyl, propofol, and
sevorein. Curarization was achieved with pancuronium bromide.
Cefazolin was administered intravenously for antimicrobial pro-
phylaxis at a dose of 1 g at the induction of anesthesia and
followed by 1 g every 6 hours for 24 hours. Postoperatively, both
groups of patients were admitted to the intensive care unit. The
patients were extubated as soon as clinically indicated.
Off-pump Technique
After median sternotomy, all patients were heparinized (100 U/kg)
to achieve an activated clotting time of greater than 250 seconds.
The distal anastomoses were completed with the use of mechanical
stabilizers for immobilization of the myocardial surface at the site
of the target coronary artery (Octopus, Medtronic). Two 4-0
polypropylene sutures were used to temporarily occlude the cor-
onary artery on either side of the anastomosis site to obtain a
bloodless field. Revascularization of the left anterior descending
coronary artery with the left internal thoracic artery was performed
first, which was followed by the revascularization of the right
coronary artery and circumflex distributions. The proximal anas-
tomoses were performed before the distal anastomoses with the
assistance of a partial occlusion aortic clamp. The total coronary
occlusion times required for the completion of all distal anasto-
moses were recorded. Heparin was not reversed with protamine
sulfate.
CPB Technique
After median sternotomy, all patients were given 300 to 400 U/kg
heparin, and after standard cannulation, patients were placed on
CPB. Nonpulsatile pump (Delphin 7850 centrifugal pump, 3M)
and membrane oxygenators (Dideco D 703 Compactflo System)
were used in all operations. The pump priming consisted of Ringer
lactate (1500 mL), 20% mannitol (150 mL), and 8.4% sodium
bicarbonate (60 mL). Activated clotting times were maintained at
a minimum of 400 seconds, hematocrit levels were maintained at
approximately 20% to 25%, and the pump flow was set at 2.2 to
2.4 L/m2/min. Patients were cooled to 28°C. For myocardial pro-
tection, potassium-based cold blood cardioplegia was intermit-
tently administered, and cold (4°C) Ringer solution was topically
applied to the heart. In every instance the left internal thoracic
artery was used as a left anterior descending coronary artery graft.
On discontinuation of CPB, heparin was neutralized with prota-
mine sulfate.
Time Points of Blood Sampling for Endotoxin,
Lactate, and Cardiac Index Measurement
Blood sampling for endotoxin, lactate, and cardiac index measure-
ments (assessed by means of thermodilution) was performed dur-
ing the following time points: (1) after sternotomy in both study
groups; (2) during the coronary occlusion period of the last distal
anastomosis in the off-pump group and during aortic crossclamp-
ing in the CPB group; (3) after removal of the coronary occlusion
sutures in the off-pump group and after removal of the aortic
crossclamp in the CPB group; (4) 30 minutes after the completion
of all distal anastomoses in the off-pump group and immediately
after weaning from CPB in the CPB group; (5) 1 hour postoper-
atively in both study groups; and (6) 12 hours postoperatively in
both study groups. Rectal temperatures and electrocardiographic
changes were recorded at all points during the study.
All blood samples were obtained from the radial artery, except
during the CPB period in the CPB group, when samples were taken
from the arterial blood outlet of the oxygenator. Samples were
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obtained from the prime solutions in the CPB group and from
transfused blood and blood products in both study groups for
endotoxin measurement.
All blood samples were collected in an aseptic fashion into
sterile, endotoxin-free, silicon-coated tubes (Terumo Venoject,
Europe N.V. 3001) and kept at room temperature for 30 minutes
before centrifugation. Samples were stored at 70°C.
At the first postoperative day, blood, urine, and catheter cul-
tures were obtained from all patients.
Measurement of Endotoxins
All glassware was covered with aluminum foil and heated in a
hot-air oven at 200°C for 4 hours.
Endotoxin levels were measured by using the quantitative
chromogenic Limulus amebocyte lysate (LAL) assay with the QCL
1000 kit (product number E50-640, lot number L3330, Biowhit-
taker, Inc). The kit contained lyophilized LAL, lyophilized endo-
toxin (Escherichia coli 0111:B4), and chromogenic substrate. Ly-
ophilized endotoxin was resuspended in pyrogen-free water as
stock solution. Serial endotoxin dilutions were made with pyrogen-
free water to cover the concentration range of 0.1 to 1.0 EU/mL.
Samples were diluted 1:10 with sterile endotoxin-free water
and heat treated for 10 minutes at 70°C to remove inhibitors. Then
they were kept at room temperature for 15 minutes. Samples were
processed in microtiter plates. Fifty microliters of sample was
incubated for 30 minutes at 37°C with 50 L of LAL. In the
second step 100 L of chromogenic substrate was added, and the
mixture was incubated for 6 minutes at 37°C. The reaction was
terminated with 100 L of 10% sodium dodecylsulfate solution.
Absorbance of each sample was read at 405 nm in an enzyme-
linked immunosorbent assay plate reader. The concentrations of
endotoxins in the samples were calculated from standard endo-
toxin measurements.
Statistical Analysis
Data are expressed as the means  SD. The significance of
difference between groups was assessed by using the Student t test,
the Mann-Whitney U test, the 2 test, or the Fischer exact test, as
appropriate.
Results
Patients
The patients’ clinical data are listed in Table 1. No great
variation was observed among patients’ demographic data.
None of the patients in both study groups required periop-
erative pharmacologic support, including inotropes and va-
sopressors. All of the patients recovered uneventfully, ex-
cept for 2 patients in the CPB group, who required surgical
re-exploration for bleeding. All blood, urine, and catheter
culture results were negative.
Endotoxin Concentrations in Samples
Endotoxins were not found in the prime solutions in the
CPB group or in samples obtained from transfused blood
and blood products in both study groups.
Figure 1 shows blood endotoxin levels. Endotoxin con-
centrations at different time points were as follows: (1)
0.38  0.2 EU/mL after sternotomy in the off-pump group
and 0.42  0.2 EU/mL in the CPB group (P  .6); (2)
1.96  0.7 EU/mL during the coronary occlusion period of
the last distal anastomosis in the off-pump group and 2.7 
0.4 EU/mL during aortic crossclamping in the CPB group
(P  .0011); (3) 1.93  0.7 EU/mL after removal of the
coronary occlusion sutures in the off-pump group and
TABLE 1. Clinical data
Off-Pump group
(n  15)
CPB group
(n  15) P value
Preoperative data
Age (y) 60.3 10 62.1 7 .5
Male (No.) 11 (73%) 14 (93%) .3
BSA (m2) 1.8 0.11 1.8 0.9 .7
EF (%) 46 5 44 5 .2
Parsonnet score 3.3 3 2.7 1.8 .9
Perioperative data
No. of graft 1.5 0.7 2.4 0.5 .0009
TCO time*/crossclamp time† (min) 33.7 17 60 16 .0002
CPB time (min) 93.2 17 —
OR time (min) 182 52 251 23 .0002
Postoperative data
Transfusion of blood products (mL) 580 174 1226 406 .0001
Total chest drainage (mL) 830 156 1022 196 .8
Time on ventilator (h) 7 3 10 4 .055
ICU stay (h) 24 13 24 12 .8
Stay in hospital (d) 6 2 6.9 2 .3
BSA, Body surface area; EF, ejection fraction; TCO, total coronary occlusion; OR, operating room; ICU, intensive care unit.
*For the off-pump group.
†For the CPB group.
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2.87 0.5 EU/mL after removal of the aortic crossclamp in
the CPB group (P  .0008); (4) 2.2  0.6 EU/mL 30
minutes after the completion of all distal anastomoses in the
off-pump group and 2.85  0.4 EU/mL immediately after
weaning from CPB in the CPB group (P .0062); (5) 2.2
0.5 EU/mL 1 hour postoperatively in the off-pump group
and 2.81  0.7 EU/mL in the CPB group (P  .0014); and
(6) 2.15  0.5 EU/mL 12 hours postoperatively in the
off-pump group and 2.6  0.6 EU/mL in the CPB group
(P  .04).
Cardiac Index, Arterial Lactate, and Rectal
Temperature Measurements
Cardiac index and arterial lactate measurements are shown
in Figures 2 and 3, respectively.
The maximum rectal temperature of the patients within
12 hours postoperatively was 37.9°C  0.7°C in the off-
pump group and 38.8°C  0.7°C in the CPB group, which
showed a significant difference (P  .009).
Discussion
Endotoxemia is known to occur in most patients undergoing
operations involving CPB, although the origin of the endo-
toxin remains a subject of great debate.2-11
Two possible factors, endogenous and exogenous, have
been incriminated.18 Normally, intestinal flora contain a
large amount of endotoxin from gram-negative microorgan-
isms.19 Many of the bacteria in the intestine are dead, and
thus endotoxin can also enter the blood stream contained
within cell-membrane fragments of dead bacteria.19 Previ-
ous studies have shown that CPB causes splanchnic isch-
emia by means of capillary closure and shunting.20 Intesti-
nal ischemia impairs intestinal wall permeability and causes
the endotoxin to pass into circulation.21 Jansen and associ-
ates10 proposed that endotoxin levels might be related to the
degree of initial vasoconstriction and the degree of the
hypo-oncotic state during CPB. The type of flow during
CPB has been postulated to play a role in inducing endo-
toxin release.3,7,11
It has been shown that endotoxin levels increase when
hypothermia deepens, probably because of intestinal isch-
emia, decreasing intestinal motility, lower enzyme activity,
and impaired function of Kuppfer cells.22
Endotoxins are ubiquitously present in the environment
and are stable and difficult to eliminate. Endotoxin has been
detected in intraoperatively administered fluids.2 Apart from
the infusion solution components of the extracorporeal
setup, several types of pharmaceutical and medical techni-
cal materials, such as dialysis membranes, filters, and sur-
gical material, such as instruments and gloves, must also be
considered.8 Better procedures in making fluids and utensils
more pyrogen free might be of great importance, together
with optimal aseptic procedures in the operating room.2
Figure 1. Endotoxin levels. Data are presented as means, and
error bars represent SDs. For sampling time points, see text. *P <
.005; #P < .05.
Figure 2. Cardiac indices assesed by means of thermodilution.
Data are presented as means, and error bars represent SDs. For
measurement time points, see text.
Figure 3. Arterial lactate levels. Data are presented as means, and
error bars represent SDs. For sampling time points, see text. *P <
.001; #P < .05.
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In our study comparisons for time points 2, 3, and 4 were
not identical in both groups. Despite these artificial com-
parisons in terms of time periods, the differences were
significant at all times during both operations, except after
sternotomy. Although we detected relatively lower endo-
toxin levels in the off-pump surgery group compared with
those in the conventional CPB group, endotoxemia occurred
during off-pump surgery. This might be explained by ex-
ogenous factors. On the other hand, with the hemodynamic
changes frequently observed during off-pump surgery, it is
not unlikely that endogenous release of endotoxins from the
intestines might have contributed to the endotoxemia. The
gut is one of the most susceptible organs to hypoperfusion
during conditions of trauma or stress.23-25 Studies have
shown that during periods of hypovolemia, the gut vaso-
constricts, thus shunting blood toward “more vital organs,”
such as the heart and brain.23-25 In addition to hypovolemic
administration of vasoconstrictors, such as phenylephrine,
to increase blood pressure, endogenously released vasocon-
strictors (eg, angiotensin II, thromboxane A2, and vasopres-
sin), low central venous pressures, and lower fluid balance
were associated with intestinal hypoperfusion.19 Hemody-
namics change during different stages of the operation; in
other words, cardiac index decreases during elevation of the
heart, and temporary occlusion of the coronary arteries
might likely lead to a reduction of gut perfusion. However,
in this study we did not collect simultaneous blood samples
from the inferior and superior vena cavae, and we compared
the endotoxin concentrations to support this hypothesis.
The results of the study have shown that blood lactate
levels were significantly higher in the CPB group. This
might be explained by numerous pathophysiologic effects
of CPB and hypothermia. However, an anaerobic metabo-
lism is not the only source of lactate. Evidence suggests that
the lactate accumulation in sepsis is not the result of oxygen
deprivation.26 The culprit might be endotoxin, which blocks
the actions of pyruvate dehydrogenase enzyme that moves
pyruvate into mitochondria. Pyruvate then accumulates in
the cell cytoplasm and is converted to lactate. Endotoxin
infusion to animals has been associated with a progressive
increase in blood lactate levels.27 The relatively high endo-
toxin levels in the CPB group might have been a contrib-
uting factor to the high lactate levels seen in this group
compared with those in the off-pump group. However,
whether this effect of endotoxin could be evident at the
observed endotoxin concentrations in the present study is
questionable.
Endotoxins have been recognized to have profound bio-
logic effects with the ability to activate different cascade
systems, such as complement, coagulation, and white blood
cells, and might produce a range of clinical symptoms from
headache, chills and myalgia over fever, hypotension, and
metabolic acidosis to septic shock and disseminated intra-
vascular coagulation.28-30 Despite the relatively high endo-
toxin levels in the CPB group, no intraoperative or postop-
erative complications were found. There are, however, good
reasons to believe that endotoxemia results are negative for
the postoperative condition of the patient and should there-
fore be minimized.8 Some of the endotoxin-related symp-
toms might be easily masked and overlooked in the early
postoperative course.
In conclusion, this study has shown that endotoxemia
during CABG surgery seems mainly to be associated with
CPB procedure. Although the initiation of endotoxemia is
coincident with CPB, the mechanisms remain to be eluci-
dated. The relatively lower endotoxin levels observed in
off-pump surgery might contribute to improved recovery
from surgical revascularization procedures, particularly in
critically ill patients.
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